beta

AGEN

Agenus Inc.

Agen

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Agenus Inc along with its subsidiaries is a pharmaceutical company. It is engaged in discovery and development of revolutionary new treatments that engage the body's immune system to benefit patients suffering from cancer.

Market Cap: 375 Million

Primary Exchange: NASDAQ Capital Market

Website: http://www.agenusbio.com

Shares Outstanding: 100 Million

Float: 92.6 Million

Dividend: 0.0 (0.0%)

Beta: 2.099262

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 9.25 Million

Ethical Flags

Animal testing

Longest drawdown: 1090 trading days

From: 2015-06-17 To: 2019-10-11

Lowest Point:

Agenus to Host Annual Meeting of Stockholders

via: PR Newswire at 2019-06-13 11:48:00:000

LEXINGTON, Mass. , June 13, 2019 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune modulating antibodies, cancer vaccines, adjuvants and adoptive cell therapies 1 , invites investors and the general public to attend its annual meeting of stoc… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud